HomeInsightsStock Comparison

Stallion India Fluorochemicals Ltd vs Tatva Chintan Pharma Chem Ltd Stock Comparison

Stallion India Fluorochemicals Ltd vs Tatva Chintan Pharma Chem Ltd Stock Comparison

Last Updated on: May 27, 2025

Key Highlights

  • The Latest Trading Price of Stallion India Fluorochemicals Ltd is ₹ 73.64 as of 27 May 15:30.
  • The P/E Ratio of Stallion India Fluorochemicals Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Tatva Chintan Pharma Chem Ltd changed from 53.4 on March 2022 to 83.2 on March 2024 . This represents a CAGR of 15.93% over 3 years.
  • The Market Cap of Stallion India Fluorochemicals Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Tatva Chintan Pharma Chem Ltd changed from ₹ 5115 crore on March 2022 to ₹ 2525 crore on March 2024 . This represents a CAGR of -20.96% over 3 years.
  • The revenue of Stallion India Fluorochemicals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Tatva Chintan Pharma Chem Ltd for the Mar '25 is ₹ 108.59 crore as compare to the Dec '24 revenue of ₹ 85.94 crore. This represent the growth of 26.36%.
  • The ebitda of Stallion India Fluorochemicals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Tatva Chintan Pharma Chem Ltd for the Mar '25 is ₹ 9.67 crore as compare to the Dec '24 ebitda of ₹ 7.1 crore. This represent the growth of 36.2%.
  • The net profit of Stallion India Fluorochemicals Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Tatva Chintan Pharma Chem Ltd changed from ₹ 9.5 crore to ₹ 1.03 crore over 8 quarters. This represents a CAGR of -67.07% .
  • The Dividend Payout of Stallion India Fluorochemicals Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Tatva Chintan Pharma Chem Ltd changed from 19.56 % on March 2021 to 15.94 % on March 2024 . This represents a CAGR of -4.99% over 4 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Stallion India Fluorochemicals Ltd

  • Stallion India Fluorochemicals Ltd was incorporated as Private Limited Company in the name of 'Stallion India Fluorochemicals Private Limited' in Mumbai on September 05, 2002, by the RoC. The Company got converted to Public Limited and name of the Company was changed to Stallion India Fluorochemicals Limited through a fresh Certificate of Incorporation dated October 05, 2023 issued by the RoC. Stallion India Fluorochemicals Limited, commonly known as Stallion, is a Mumbai-based company founded by Shazad Sheriar Rustomji.
  • The Company is engaged in manufacture of industrial gases.
  • It operate 4 strategically located Plants in Khalapur, Raigad (Maharashtra); Ghiloth, Alwar (Rajasthan); Manesar, Gurugram (Haryana); and Panvel, Raigad (Maharashtra).
  • Their specialty gases mainly fall within the Hydrofluorocarbons (HFC) and Hydrofluoroolefins (HFO) categories, finding diverse applications across various industries.

About Tatva Chintan Pharma Chem Ltd

  • Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996.
  • The status of the Company converted from Private Limited into a Public Limited Company effective from 27 January 2021 and the name of Company also changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'.
  • The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is a globally recognized specialty chemical player with several market leading products in its portfolio.
  • The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), , Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC).

Stallion India Fluorochemicals Ltd News Hub

News

Stallion India Fluorochemicals declare Quarterly Result

Stallion India Fluorochemicals will hold a meeting of the Board of Directors of the Compan...

Read more

10 May 2025 15:18

News

Stallion India Fluorochemicals spurts on debut

The scrip was listed at Rs 120, exhibiting a premium of 33.33% to the issue price. So far,...

Read more

23 Jan 2025 10:30

Tatva Chintan Pharma Chem Ltd News Hub

News

Tatva Chintan Pharma Chem wins export order of USD 35,55,000

Tatva Chintan Pharma Chem has received an export order worth of USD 35,55,000 (approx. Rs ...

Read more

05 May 2025 17:05

News

Board of Tatva Chintan Pharma Chem recommends Final Dividend

Tatva Chintan Pharma Chem announced that the Board of Directors of the Company at its meet...

Read more

02 May 2025 17:20

News

Tatva Chintan Pharma Chem to declare Quarterly Result

Tatva Chintan Pharma Chem will hold a meeting of the Board of Directors of the Company on ...

Read more

26 Apr 2025 10:25

News

Tatva Chintan Pharma Chem declare Quarterly Result

Tatva Chintan Pharma Chem will hold a meeting of the Board of Directors of the Company on ...

Read more

17 Jan 2025 17:27

News

Tatva Chintan Pharma Chem to discuss results

Tatva Chintan Pharma Chem will hold a meeting of the Board of Directors of the Company on ...

Read more

17 Oct 2024 16:28

News

Tatva Chintan Pharma Chem AGM scheduled

Tatva Chintan Pharma Chem announced that the Annual General Meeting (AGM) of the company w...

Read more

28 Aug 2024 14:54

SWOT Analysis Of Tatva Chintan Pharma Chem Ltd

Strength

3

S

Weakness

2

W

Opportunity

1

O

Threats

1

T

BlinkX Score for Tatva Chintan Pharma Chem Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Stallion India Fluorochemicals Ltd and Tatva Chintan Pharma Chem Ltd

Which company has a larger market capitalization, Stallion India Fluorochemicals Ltd or Tatva Chintan Pharma Chem Ltd?

Market cap of Stallion India Fluorochemicals Ltd is 584 Cr while Market cap of Tatva Chintan Pharma Chem Ltd is 2,108 Cr

What are the key factors driving the stock performance of Stallion India Fluorochemicals Ltd and Tatva Chintan Pharma Chem Ltd?

The stock performance of Stallion India Fluorochemicals Ltd and Tatva Chintan Pharma Chem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Stallion India Fluorochemicals Ltd and Tatva Chintan Pharma Chem Ltd?

As of May 27, 2025, the Stallion India Fluorochemicals Ltd stock price is INR ₹73.64. On the other hand, Tatva Chintan Pharma Chem Ltd stock price is INR ₹901.5.

How do dividend payouts of Stallion India Fluorochemicals Ltd and Tatva Chintan Pharma Chem Ltd compare?

To compare the dividend payouts of Stallion India Fluorochemicals Ltd and Tatva Chintan Pharma Chem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions